John Erickson is a dynamic and strategic senior global health care business leader with success-based experience from Fortune 50 to start-up’s with diabetes, clinical diagnostic and life science companies. John has been recognized for proven leadership in delivering superior results, developing profitable growth strategies and building high performance teams. Additionally, John has been responsible for the development, launch and management of over 3 dozen scientific products with cumulative revenues in excess of $3 billion and has raised more than $50 million in investment capital.
John’s experiential portfolio and business acumen also includes: strategy development and execution, capital funding, global commercial deployment with both global direct and distribution models, talent acquisition, organizational design and cultural change management, numerous global new product launches, sales force deployment and re-engineering, joint venture management, corporate partnerships, product licensing agreements, intellectual property strategy, portfolio rationalization, Digital Health and Point of Care (POC) expertise, and emerging market development expertise.
John holds a Master of Science Degree in Management, Bachelor of Science degrees in both Chemistry and Biology, as well as graduate studies in Biochemistry, Toxicology and Endocrinology. He has Board of Directors experience with for-profit organizations, several healthcare industry councils and non-profit organizations.